Niacinamide 2% - evens out skin tone, antioxidant, works well with post-acne marks
The procedure is performed using a sterile, single-use needle head for each patient, ensuring the highest standards of safety and hygiene
Quick Comparison Feature CagriSema Retatrutide Development owner Novo Nordisk Eli Lilly Core strategy Combination therapy Single-molecule multi-agonist Pathways Amylin + GLP-1 GIP + GLP-1 + glucagon Main components Cagrilintide + semaglutide Retatrutide (LY3437943) 2026 status Phase 3 / regulatory-watch candidate Phase 3 TRIUMPH program Best-fit research question Can amylin extend GLP-1 results
Joint and Muscle Recovery: Supporting a healthy inflammatory response after exercise can help you stay active for longer
Reconstitution reference U100 units to draw for each common Retatrutide dose, by vial size, reconstituted with 2 mL of bacteriostatic water
Skin Tone & Pigmentation 80.65% agreed their skin looks more even 80.65% agreed their skin tone looks improved 74.19% agreed it corrects uneven-looking skin tone 74.19% agreed it fades the look of dark spots 77.42% agreed the look of discolouration is lighter Radiance & Overall Skin Appearance 96.77% agreed their skin is visibly brighter 93.55% agreed their skin looks more radiant and luminous 93.55% agreed their skin looks healthier 93.55% agreed their skin looks less dull 90.32% agreed their skin looks younger with a youthful glow 90.32% agreed their skin is visibly improved overall 74.19% agreed their complexion is clearer Product Experience 87.10% said they would recommend this product 77.42% said it is a great addition to their skincare routine 74.19% said they love how it makes their skin look and feel 70.97% agreed it visibly improves signs of ageing Summary of Key Results The results of this independent 12-week clinical trial are clear and consistent: Altrient Glutathione produces statistically significant, measurable improvements in both skin redness and hyperpigmentation, confirmed across multiple validated assessment methods and a diverse participant population
